Experimental evaluation of acute toxicity heterometalic new compounds – tartratogermanat cooper and zinc

Authors

  • G. P. Paniotova Odesa National Medical University, Ukraine,
  • P. B. Antonenko Odesa National Medical University, Ukraine,
  • V. V. Godovan Odesa National Medical University, Ukraine,
  • I. I. Seifullina Odesa National University by Mechnikov, Ukraine,
  • O. A. Chebanenko Odesa National University by Mechnikov, Ukraine,
  • K. H. Lobashova Odesa National Medical University, Ukraine,

DOI:

https://doi.org/10.14739/2310-1210.2017.6.115271

Keywords:

acute toxicity tests, copper, zinc

Abstract

One of the possible ways of creating new drugs is aiming synthesis of compounds previously envisaged activity. Perspective in this area is to obtain complexes based on metal ions and ligands.

Purpose: To establish toxikometric characteristics of new biologically active substances - tartratogermanat copper and zinc in the acute experiment.

Materials and Methods: Studied acute toxicity in mice and rats under the conditions of oral (o), subcutaneous (s / c) and intraperitoneal (i / p) administration. The toxicity criterion of the test compounds was LD50, which was determined using the probit analysis method. In addition, a number of integrated toxicity indicators were calculated, in particular absolute toxicity, an acute toxic effect zone, a summary toxicity index and etc.

The results: According to the results, the LD50 index of copper-tartratogermanate in mice was 36.88 mg / kg (i / p) 63.78 mg / kg (s / c) and 385.57 mg / kg (o); in rats - 78.16; 135.05 and794.26 m / kg, accordingly. The LD50 index of zinc-tartratogermanate in mice was 87.20 mg / kg (i / p) 167.05 mg / kg (s / c) and 1675.40 mg / kg (o); in rats - 141.57; 236.52 and 2792.45 μ / kg, accordingly. The new compound of zinc tartratogermanat belongs to low-toxic compounds (IV class of toxicity) in conditions of intraperitoneal, subcutaneous and oral administration in two animal species, in the same time-tartratogermanat copper is moderately toxic (toxicity class III). Zinc-containing compounds showed lower toxicity than similar compounds with cuprum. According to the resalts, the variability of the lethal doses for various routes of administration of copper tartrate-hommanate was 1.32-1.60 (in mice) and 1.66-1.92 (in rats) zinc tartrate-germanate, 1.31-1.50 (in mice) and 1.24-1.37 (in rats). Integral safety of the new BAС showes that compounds with zinc were more safety in oral take, while new compounds containing copper were the safest under conditions of injection.

Conclusions: A small toxicity of new compounds tartratogermanat zinc and copper indicates the prospects for their further preclinical studies as potential drugs.a.

References

Kiselev, Yu. M. (2008) Khimiya coordinacionykh soedinenij [Chemistry of coordinating compounds]. Moscow: Integral-Press. [in Russian].

Lu, P., Yao, S., Cai, J., & Yang, P. H. (2014) Synthesis and synergetic anti-tumor activity evaluation of dihydroartemisinin-organogermanium(IV)compound. Bioorg. Med. Chem. Lett., 24(22), 5294–5297. doi: 10.1016/j.bmcl.2014.09.048.

Nakamura, T., Takeda, T., & Tokuji, Y. (2014) The oral intake of organic germanium, Ge-132, elevates α-tocopherol levels in the plasma and modulates hepatic gene expression profiles to promote immune activation in mice. Int. J. Vitam. Nutr. Res., 84(3–4), 183–195. doi: 10.1024/0300-9831/a000205.

Tymchyshyn, O. L. (2015) Farmakolohichna aktyvnist novoi biolohichno-aktyvnoi rechovyny-kuprum-oksietylidendyfosfonatohermanatu (Avtoref. dis…kand. med. nauk). [Pharmacological activity of new biologically active compound – cuprum-oxyethylidenbiphosphonatogermanate]. (Extended abstract of candidate’s thesis). Оdesa. [in Ukrainian].

Varbanets, O. I. (2014) Neirotropna diia novykh hermaniiorhanichnykh spoluk (eksperymentalne doslidzhennia). (Avtoref. dis…kand. med. nauk) [Neurotropic action of new germanium-containing compounds (experimental research)]. (Extended abstract of candidate’s thesis). Оdesa. [in Ukrainian].

Seifullina, I. I., Martsinko, E. E., Chebanenko, E. A., Ilyukhin, A. B., & Sergienko, V. S. (2014) Strukturnye osobennosti tartratogermanatnykh(IV) kompleksov medi(II) i lantanidov(III) [Structural features of copper(II) and lanthanide(III) tartratogermanate(IV) complexes]. Zhurnal neorganicheskoj khimii, 59, 452–456. [in Russian].

Hodovan, V. V., Matiushkina, M. V., Seifullina, I. I., Hridina, T. L., Chebanenko, O. A., & Fedchuk, A. S. (2014). Patent Ukrainy 95565 MPK (2006.01) A61K 31/19 Koordynatsiina spoluka kobalt bis(tsytrato)stanat z protyhrypoznoiu diieiu [Patent of Ukraine, Coordinational compound of cobalt bis (citrate) stanate with influenza action]. Biuleten, 24/2014. [in Ukrainian].

Chekman, I. S., Ulberg, Z. R., Rudenko, A. D., Marushko, Yu. V., Grusina, T. G., Reznichenko, L. S., et al. (2013) Tsynk i nanotsynk: vlastyvosti, zastosuvannia u klinichnii praktytsi [Zinc and nanozinc: properties, application in clinical practice]. Ukrainskyi medychnyi chasopys, 2(94), 42–47. [in Ukrainian].

Hordyjewska, A., Popiołek, Ł., & Kocot, J. (2014) The many «faces» of copper in medicine and treatment. Biometals, 27(4), 611–621. doi: 10.1007/s10534-014-9736-5.

Park, K. C., Fouani, L., Jansson, P. J., Wooi, D., Sahni, S., Lane, D. J R., et. al. (2016), Copper and conquer: copper complexes of di-2-pyridylketone thiosemicarbazones as novel anti-cancer therapeutics. Metallomics, 8(9), 874–886. doi: 10.1039/C6MT00105J.

Stephanova, А. V. (Ed) (2002) Doklinichni isledovaniya lekarstvenukh sredstv [Preclinical studies of medical agents]. Кyiv: Avicena. [in Russian].

Prozorovskij, V. B. (1962). Ispol'zovanie metoda naimen'shikh kvadratov dlya probit-analiza krivykh letal'nosti [Using the method of least s for squares probit analysis of mortality curves]. Farmakologiya i toksikologiya, 25(1), 115–119. [in Russian].

Sidorov, K. K. (1973) Toksikologiya novykh promyshlennykh khimicheskikh veshchestv [Toxicology of new industrial chemicals]. Moscow: Medicina. [in Russian].

Paniotova, G. P., Antonenko, P. B., Godovan, V. V., & Seifullina, І. I. (2016) Hostra toksychnist novoi koordynatsiinoi spoluky – hermaniievoi soli dyfosfonovoi kylosty z tsynkom [Acute toxicity of new coordinating compound – germanium salt of diphosphonic acid with zinc]. Odeskyi medychnyi zhurnal, 6, 42–47. [in Ukrainian].

Downloads

How to Cite

1.
Paniotova GP, Antonenko PB, Godovan VV, Seifullina II, Chebanenko OA, Lobashova KH. Experimental evaluation of acute toxicity heterometalic new compounds – tartratogermanat cooper and zinc. Zaporozhye Medical Journal [Internet]. 2017Nov.15 [cited 2024Nov.25];(6). Available from: http://zmj.zsmu.edu.ua/article/view/115271

Issue

No. 6 (2017)

Section

Original research

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.  Лицензия Creative Commons
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)